RegisterLogin

Peficitinib (hydrobromide)

CAT: 0804-HY-19568ASize: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-19568ASize:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Peficitinib (ASP015K) hydrobromide is an orally active JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively[1].
CAS Number
[1353219-05-2]
Product Name Alternative
ASP015K (hydrobromide) ; JNJ-54781532 (hydrobromide)
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/peficitinib-hydrobromide.html
Solubility
10 mM in DMSO
Smiles
O[C@](C[C@@H]1C[C@H]2C3)(C2)C[C@@H]3[C@H]1NC4=C5C(NC=C5)=NC=C4C(N)=O.Br[H]
Molecular Formula
C18H23BrN4O2
Molecular Weight
407.30
References & Citations
[1]Ito M, et al. A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model. J Pharmacol Sci. 2017 Jan;133 (1) :25-33.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
JAK1; JAK2; JAK3; Tyk2

Related Products

CatalogName
HY-19568-01Peficitinib
HY-19568R-01Peficitinib (Standard)
HY-19568BPeficitinib (hydrochloride)
HY-18200BAtopaxar (hydrobromide)
HY-127022AAnisodine (hydrobromide)
HY-N2482A-01Guvacine (hydrobromide)
HY-113843RETRA (hydrobromide)
HY-125971Xylopropamine (hydrobromide)
HY-121650AADTN (hydrobromide)
HY-N8580Hydrocotarnine (hydrobromide)

Alternative Products

CatalogName
T33905-01Peficitinib hydrobromide
M16761-01Peficitinib
T61365-01Peficitinib hydrochloride
RM-P050609-01Peficitinib Impurity 9
B2623-1EZSolution™ Peficitinib
A14438-5Peficitinib 5mg
A14438-10Peficitinib 10mg
A14438-25Peficitinib 25mg
RM-P050605-01Peficitinib Impurity 5
RM-P050608-01Peficitinib Impurity 8

Popular Products